The Singapore Art-Health Study

July 12, 2023 updated by: Andy Hau Yan Ho, PhD, EdD, Nanyang Technological University

Effects of Participatory Art-Based Activity On Health of Older Community-Dwellers: The Singapore Art-Health Randomized Control Trial Study

The goal of the Singapore Art-Health RCT is to examine the effect of a standardized 12-week museum -based participatory art program on health condition, well-being, and quality of life in older community dweller, one that adheres to the Montreal Art-Health framework with culturally specific modifications that are fitting to the local Singaporean context.

Participants will be randomized into an intervention group of a passive control group. Participants in the intervention group will be invited to participate in the 12-week Singapore Art-Health Intervention held at the National Gallery Singapore. All participants will be invited to complete four online psychometric assessments. Participants in the intervention group will be invited to completed an additional post-intervention survey and a feasibility focus group.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background: Population aging continues to be global health challenge. The prevalence of longstanding age-related conditions such as worsening physical, social, and mental health is expected to increase exponentially with a rapidly ageing population. The practice of participatory art in various settings has been found to be effective in the promotion, prevention and management of health and wellbeing conditions across the life span. However, its effect on health condition among the older population, particularly in the Asian context remains to be investigated. In Montreal, findings from a pilot study provided strong evidence to show that a 12-week, standardized "Art-Health" participatory art program had multidimensional positive effects on the health outcomes of older community dwelling participants including improvements in wellbeing, quality of life, and frail condition.

Current Proposal: The current research will adopt and modify the Montreal Art-Health participatory art framework with local cultural specificity (i.e. The Singapore Art-Health Intervention), and tests its effectiveness in healthy and wellness promotion among a sample of Singaporean older adults via a randomized control trial.

Research Design: The study adopts a participatory action research paradigm and a single-site, open-label Randomized Control Trial (RCT) design to develop and examine the effect of a standardized 12-week museum-based participatory art activity on health condition, wellbeing, and quality of life in older community dwellers.

Sampling and Randomization: Allowing for an attrition rate of 5% at follow-up, a target sample of 110 provides 90% power to detect an effect size of 0.55 (based on the results of the pilot study) between the intervention group and the control group at 5% level of significance (two-tailed test). Participants will be randomized into an intervention group of a passive control group. Participants in the intervention group will be invited to participate in the 12-week Singapore A-Health Intervention held at the National Gallery Singapore.

Intervention Design: The Singapore Art-Health Intervention will span 12 weeks, with each weekly session lasting for two hours. The program is designed to impart basic art appreciation skill (formal analysis in art) and art making techniques to participants through engagement with the collection at the museum.

Outcome measures and Data Analysis: All participants will be invited to complete four online psychometric assessments. Participants in the intervention group will be invited to completed an additional post-intervention survey and a feasibility focus group. For the quantitative data, between and within comparisons of outcomes will be conducted by mixed model analysis of variance (ANOVA), repeated measures ANOVA, and pairwise t-tests with Bonferroni correction. The focus group discussions will be analyzed using thematic analysis with a grounded theory approach to provide insights to the participant's experience and impact of the Singapore Art-Health Intervention.

Importance of Research: The current research will develop and test the effectiveness of a culturally-specific Art-Health participatory art program on health and wellness promotion among a sample of Singaporean older adults. Working collaboratively with the National Gallery Singapore in program development and implementation will serve to ensure program sustainability upon research completion. This collaboration will also foster practice and knowledge transfer to accelerate creative ageing in the local society. Moreover, the findings will contribute to an international RCT for evaluating a standardized participatory art framework to address the impact of population ageing. It will be a potential breakthrough in the development of an efficient art and museum program for older adults locally and internationally.

Study Type

Interventional

Enrollment (Actual)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore, 637332
        • Nanyang Technological University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • individuals above the age of 60,
  • fluent in English
  • able to access the internet to complete the online psychometric assessments

Exclusion Criteria:

  • unable to provide informed consent
  • diagnosed with mental health conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Singapore A-Health Group
A 12-week professionally led participatory art program at the gallery with each week comprising one 2-hour art session, totaling 24 hours of museum tours and participatory art activities.
Behavioral: Singapore A-Health Intervention
The Singapore A-Health Intervention spanned 12 weeks, with each weekly session lasting for two hours. The program is structured around three thematic domains of the past, present, and future. In each thematic domain consisting of four weeks, participants were tasked with creating an artwork related to the theme and incorporating the learned art techniques. The structure of each thematic domain follows the same structure: the first week involved a 45-minute docent-led gallery tour on three selected pieces of artworks, followed by a 75-minute artist-led brainstorming session where participants were introduced to the techniques and discuss ideas on the artwork to be created. The subsequent three sessions involved further guidance from the artist and a scaffolded delivery of art techniques for participants to incorporate their learning to their artwork. At the end of each domain, there was a showcase where participants present their artwork.
No Intervention: Control Group
No art-based activities offered and advised not to participate in concurrent health and art-based interventions during the 12-week research period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life (EQ5D)
Time Frame: Baseline
Quality of life will be assessed by EuroQol-5D (EQ5D) which comprised of two parts: (1) 5-item scale on mobility, self-care, daily activities, pain, and depressive symptoms, (2) a visual analog scale of the participant's perceived health ranging from 0 (worst health) to 100 (best health one can imagine)
Baseline
Change in Quality of Life (EQ5D)
Time Frame: 5-week follow-up
Quality of life will be assessed by EuroQol-5D (EQ5D) which comprised of two parts: (1) 5-item scale on mobility, self-care, daily activities, pain, and depressive symptoms, (2) a visual analog scale of the participant's perceived health ranging from 0 (worst health) to 100 (best health one can imagine)
5-week follow-up
Change in Quality of Life (EQ5D)
Time Frame: 9-week follow-up
Quality of life will be assessed by EuroQol-5D (EQ5D) which comprised of two parts: (1) 5-item scale on mobility, self-care, daily activities, pain, and depressive symptoms, (2) a visual analog scale of the participant's perceived health ranging from 0 (worst health) to 100 (best health one can imagine)
9-week follow-up
Change in Quality of Life (EQ5D)
Time Frame: 12-week follow-up
Quality of life will be assessed by EuroQol-5D (EQ5D) which comprised of two parts: (1) 5-item scale on mobility, self-care, daily activities, pain, and depressive symptoms, (2) a visual analog scale of the participant's perceived health ranging from 0 (worst health) to 100 (best health one can imagine)
12-week follow-up
Mental Wellbeing (WEMWBS)
Time Frame: Baseline
Mental Wellbeing will be assessed by Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS), a 14-item scale assessing various domains of wellbeing.
Baseline
Change in Mental Wellbeing (WEMWBS)
Time Frame: 5-week follow-up
Mental Wellbeing will be assessed by Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS), a 14-item scale assessing various domains of wellbeing.
5-week follow-up
Change in Mental Wellbeing (WEMWBS)
Time Frame: 9-week follow-up
Mental Wellbeing will be assessed by Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS), a 14-item scale assessing various domains of wellbeing.
9-week follow-up
Change in Mental Wellbeing (WEMWBS)
Time Frame: 12-week follow-up
Mental Wellbeing will be assessed by Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS), a 14-item scale assessing various domains of wellbeing.
12-week follow-up
Frailty (CESAM)
Time Frame: Baseline
Frailty will be assessed by the Centre of Excellence on Longevity Self-administered Questionnaire (CESAM). It is a 20-item scale assessing multiple aspects of health such as drug intake, memory complaints, health service utilization, and activities of daily living.
Baseline
Change in Frailty (CESAM)
Time Frame: 5-week follow-up
Frailty will be assessed by the Centre of Excellence on Longevity Self-administered Questionnaire (CESAM). It is a 20-item scale assessing multiple aspects of health such as drug intake, memory complaints, health service utilization, and activities of daily living.
5-week follow-up
Change in Frailty (CESAM)
Time Frame: 9-week follow-up
Frailty will be assessed by the Centre of Excellence on Longevity Self-administered Questionnaire (CESAM). It is a 20-item scale assessing multiple aspects of health such as drug intake, memory complaints, health service utilization, and activities of daily living.
9-week follow-up
Change in Frailty (CESAM)
Time Frame: 12-week follow-up
Frailty will be assessed by the Centre of Excellence on Longevity Self-administered Questionnaire (CESAM). It is a 20-item scale assessing multiple aspects of health such as drug intake, memory complaints, health service utilization, and activities of daily living.
12-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Nanyang Technological University

Collaborators

Sheffield Hallam University
Université de Montréal
National Gallery Singapore, Singapore

Investigators

  • Principal Investigator: Andy HY Ho, PhD, EdD, Nanyang Technological University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2021

Primary Completion (Actual)

November 30, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

July 5, 2023

First Submitted That Met QC Criteria

July 12, 2023

First Posted (Actual)

July 14, 2023

Study Record Updates

Last Update Posted (Actual)

July 14, 2023

Last Update Submitted That Met QC Criteria

July 12, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-2020-02-005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There are currently no plans o make individual participant data (IPD) available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Singapore A-Health Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe